| Trial ID: | L2326 |
| Source ID: | NCT01510522
|
| Associated Drug: |
Glucophage
|
| Title: |
Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Type 2
|
| Interventions: |
DRUG: Glucophage|DRUG: Glucophage
|
| Outcome Measures: |
Primary: Change from Baseline of Patient self-reported subjective compliance as assessed by Haynes-Sackett test at Month 6, Month 6 | Secondary: Objective compliance to treatment, Objective compliance to treatment is assessed by the accountability of medication returned. Patient is assessed as compliant with an adherence of over 80%., Month 3 and month 6|Evaluation of treatment satisfaction and preferences with the Diabetes Treatment Satisfaction Questionnaire (DTSQ), Baseline, month 3 and month 6|Rate of reported adverse events, Month 3 and month 6
|
| Sponsor/Collaborators: |
Sponsor: Merck KGaA, Darmstadt, Germany | Collaborators: Merck, S.L., Spain
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2012-06
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2014-02-04
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01510522
|
